Endoscopic Stricture Management Device Market Demand, Trends, Growth Analysis, Opportunity and Future Competition

Endoscopic Stricture Management Device Market Growth, Size, Trends Analysis - By Product, By Application, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Published: May-2025 Report ID: MEDE2526 Pages: 1 - 230 Formats*:     
Category : Medical Devices
Endoscopic Stricture Management Device Market Introduction and Overview 

According to SPER Market Research, the Global Endoscopic Stricture Management Device Market is estimated to reach USD 1681.1 million by 2034 with a CAGR of 6.05%.

The report includes an in-depth analysis of the Global Endoscopic Stricture Management Device Market, including market size and trends, product mix, Applications, and supplier analysis. The endoscopic stricture management device market grew at a compound annual growth rate (CAGR) of 6.05% during the analysis period and was projected to be valued at USD 934.3 million in 2024. The growing frequency of diseases that cause strictures, continuous technological advancements in endoscopic stricture management devices, and growing awareness of early stricture diagnosis are some of the factors propelling the market. The global market for endoscopic stricture treatment devices is also being driven by the rise in endoscopic minimally invasive surgical techniques.
By Product Insights
The global market is divided into various products, such as bougie dilators, balloon dilators, and stents. This category includes biodegradable, plastic, and metal stents. This segment dominates the market, thanks to advancements in manufacturing materials that promote biocompatibility and biodegradability. When opposed to balloon dilation, stents aid to maintain long-term luminal patency and reduce the need for repeated treatments.

By Application Insights
Based on application, the market for endoscopic stricture management devices is divided into biliary, pyloric, colonic, and esophageal sectors. The oesophageal category held the largest market share in 2024. The high frequency of strictures in the esophageal region brought on by gastric disorders such as GERD, esophageal cancer, eosinophilic oesophagitis, IBD, and corrosive injuries can be the reason for this dominance.

By End User Insights
Hospitals and ambulatory surgery centres are among the end users that make up the market for endoscopic stricture management devices. The hospital category led the market in 2024. Hospitals dominate the market due to a variety of causes. Hospitals have the required infrastructure, including as endoscopy suites, specialised endoscopic gear, and qualified personnel, to perform endoscopic treatments for stricture management safely and effectively.

Regional Insights
It is anticipated that North America will continue to dominate the market for endoscopic stricture therapy devices. Due to a variety of factors, including a rise in the incidence of stricture-causing diseases like GERD, gastrointestinal cancer, and IBD as well as heightened awareness of the significance of early stricture detection and treatment, North America has become the market leader. Furthermore, easier access to payment and coverage for endoscopic stricture management contributes to increased demand for endoscopic stricture management devices, which supplements market growth.



Market Competitive Landscape.
The market is fragmented, with both established businesses and new entrants. Additionally, market participants are emphasising the development of unique and sophisticated products that may provide patients with greater biocompatibility, improved fit, and better safety to the patients. In this dynamic climate, severe competition forces businesses to differentiate themselves through product innovation, branding, and strategic marketing initiatives to meet the growing need for endoscopic stricture management devices.

Recent Developments:
  • Medtronic, a world leader in medical technology, services, and solutions, and Cosmo Pharmaceuticals, a pioneer in the development of advanced intelligent medical devices, collaborated to launch the "GI Genius" intelligent endoscopic module in December 2023. Their goal is to use artificial intelligence to transform endoscopy and enhance patient outcomes.
Scope of the report:
 Report Metric Details
 Market size available for years 2021-2034
 Base year considered 2024
 Forecast period 2025-2034
 Segments coveredBy Product, By Application, By End User
 Regions coveredNorth America, Latin America, Asia-Pacific, Europe, and Middle East & Africa
 Companies CoveredBoston Scientific Corporation, Olympus Corporation, CONMED Corporation, Cook Medical Inc, Becton, Dickinson and Company, Merit Medical Systems, Medi-Globe GmbH, PanMed Us, HOBBS MEDICAL, INC, Micro-Tech (Nanjing) Co., Ltd, Steris plc (Diagmed Healthcare), Taewoong Medical Co., Ltd.

Key Topics Covered in the Report
  • Global Endoscopic Stricture Management Device Market Size (FY’2021-FY’2034)
  • Overview of Global Endoscopic Stricture Management Device Market
  • Segmentation of Global Endoscopic Stricture Management Device Market By Product (Stents, Balloon Dilators, Balloon Inflation Devices, Bougie Dilators)
  • Segmentation of Global Endoscopic Stricture Management Device Market By Application (Esophageal, Colonic, Pyloric, Biliary)
  • Segmentation of Global Endoscopic Stricture Management Device Market By End User (Hospitals, Ambulatory Surgery Centers)
  • Statistical Snap of Global Endoscopic Stricture Management Device Market
  • Expansion Analysis of Global Endoscopic Stricture Management Device Market
  • Problems and Obstacles in Global Endoscopic Stricture Management Device Market
  • Competitive Landscape in the Global Endoscopic Stricture Management Device Market
  • Details on Current Investment in Global Endoscopic Stricture Management Device Market
  • Competitive Analysis of Global Endoscopic Stricture Management Device Market
  • Prominent Players in the Global Endoscopic Stricture Management Device Market
  • SWOT Analysis of Global Endoscopic Stricture Management Device Market
  • Global Endoscopic Stricture Management Device Market Future Outlook and Projections (FY’2025-FY’2034)
  • Recommendations from Analyst
1. Introduction
  • 1.1. Scope of the report
  • 1.2. Market segment analysis
2. Research Methodology
  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPER’s internal database
    • 2.1.4. Premium insight from KOL’s
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation
3. Executive Summary

4. Market Dynamics
  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
5. Market variable and outlook
  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTER’s Five Forces 
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
    • 5.4. Heat Map Analysis
6. Competitive Landscape
  • 6.1. Global Endoscopic Stricture Management Device Market Manufacturing Base Distribution, Sales Area, Product Type 
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Endoscopic Stricture Management Device Market
7. Global Endoscopic Stricture Management Device Market, By Product (USD Million) 2021-2034
  • 7.1. Stents
    • 7.1.1. Metal stents
    • 7.1.2. Plastic stents
    • 7.1.3. Biodegradable stents
  • 7.2. Balloon dilators
    • 7.2.1. Balloon dilator catheters
    • 7.2.2. Balloon inflation devices
  • 7.3. Bougie dilators
  • 7.4. Other products
8. Global Endoscopic Stricture Management Device Market, By Application (USD Million) 2021-2034
  • 8.1. Esophageal
  • 8.2. Colonic
  • 8.3. Pyloric
  • 8.4. Biliary
  • 8.5. Other applications
9. Global Endoscopic Stricture Management Device Market, By End User (USD Million) 2021-2034
  • 9.1. Hospitals
  • 9.2. Ambulatory surgery centers
  • 9.3. Other end users
10. Global Endoscopic Stricture Management Device Market, (USD Million) 2021-2034
  • 10.1. Global Endoscopic Stricture Management Device Market Size and Market Share
11. Global Endoscopic Stricture Management Device Market, By Region, (USD Million) 2021-2034
  • 11.1. Asia-Pacific
    • 11.1.1. Australia
    • 11.1.2. China
    • 11.1.3. India
    • 11.1.4. Japan
    • 11.1.5. South Korea
    • 11.1.6. Rest of Asia-Pacific
  • 11.2. Europe
    • 11.2.1. France
    • 11.2.2. Germany
    • 11.2.3. Italy
    • 11.2.4. Spain
    • 11.2.5. United Kingdom
    • 11.2.6. Rest of Europe
  • 11.3. Middle East and Africa
    • 11.3.1. Kingdom of Saudi Arabia 
    • 11.3.2. United Arab Emirates
    • 11.3.3. Qatar
    • 11.3.4. South Africa
    • 11.3.5. Egypt
    • 11.3.6. Morocco
    • 11.3.7. Nigeria
    • 11.3.8. Rest of Middle-East and Africa
  • 11.4. North America
    • 11.4.1. Canada
    • 11.4.2. Mexico
    • 11.4.3. United States
  • 11.5. Latin America
    • 11.5.1. Argentina
    • 11.5.2. Brazil
    • 11.5.3. Rest of Latin America 
12. Company Profile
  • 12.1. Boston Scientific Corporation
    • 12.1.1. Company details
    • 12.1.2. Financial outlook
    • 12.1.3. Product summary 
    • 12.1.4. Recent developments
  • 12.2. Olympus Corporation
    • 12.2.1. Company details
    • 12.2.2. Financial outlook
    • 12.2.3. Product summary 
    • 12.2.4. Recent developments
  • 12.3. CONMED Corporation
    • 12.3.1. Company details
    • 12.3.2. Financial outlook
    • 12.3.3. Product summary 
    • 12.3.4. Recent developments
  • 12.4. Cook Medical Inc
    • 12.4.1. Company details
    • 12.4.2. Financial outlook
    • 12.4.3. Product summary 
    • 12.4.4. Recent developments
  • 12.5. Becton, Dickinson and Company
    • 12.5.1. Company details
    • 12.5.2. Financial outlook
    • 12.5.3. Product summary 
    • 12.5.4. Recent developments
  • 12.6. Merit Medical Systems
    • 12.6.1. Company details
    • 12.6.2. Financial outlook
    • 12.6.3. Product summary 
    • 12.6.4. Recent developments
  • 12.7. Medi-Globe GmbH
    • 12.7.1. Company details
    • 12.7.2. Financial outlook
    • 12.7.3. Product summary 
    • 12.7.4. Recent developments
  • 12.8. PanMed Us
    • 12.8.1. Company details
    • 12.8.2. Financial outlook
    • 12.8.3. Product summary 
    • 12.8.4. Recent developments
  • 12.9. HOBBS MEDICAL, INC
    • 12.9.1. Company details
    • 12.9.2. Financial outlook
    • 12.9.3. Product summary 
    • 12.9.4. Recent developments
  • 12.10. Micro-Tech (Nanjing) Co., Ltd
    • 12.10.1. Company details
    • 12.10.2. Financial outlook
    • 12.10.3. Product summary 
    • 12.10.4. Recent developments
  • 12.11. Steris plc (Diagmed Healthcare)
    • 12.11.1. Company details
    • 12.11.2. Financial outlook
    • 12.11.3. Product summary 
    • 12.11.4. Recent developments
  • 12.12. Taewoong Medical Co., Ltd
    • 12.12.1. Company details
    • 12.12.2. Financial outlook
    • 12.12.3. Product summary 
    • 12.12.4. Recent developments
  • 12.13. Others
13. Conclusion

14. List of Abbreviations

15. Reference Links

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1

SPER-Methodology-2

SPER-Methodology-3


Frequently Asked Questions About This Report
Endoscopic Stricture Management Device Market Market size is USD 1681.1 million from 2025 to 2034.
Endoscopic Stricture Management Device Market Market is covered By Product, By Application, By End User
North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa
Boston Scientific Corporation, Olympus Corporation, CONMED Corporation, Cook Medical Inc, Becton, Dickinson and Company, Merit Medical Systems, Medi-Globe GmbH, PanMed Us, HOBBS MEDICAL, INC, Micro-Tech (Nanjing) Co., Ltd, Steris plc (Diagmed Healthcare), Taewoong Medical Co., Ltd.
The report includes an in-depth analysis of the Global Endoscopic Stricture Management Device Market, including market size and trends, product mix, Applications, and supplier analysis.
Endoscopic Stricture Management Device Market Market is projected to reach USD 1681.1 million by 2034, growing at a CAGR of of 6.05% during the forecast period.
Endoscopic Stricture Management Device Market Market grew in Market size from 2025. The Market is expected to reach USD 1681.1 million by 2034, at a CAGR of 6.05% during the forecast period.
Endoscopic Stricture Management Device Market Market CAGR of 6.05% during the forecast period.
PLACE AN ORDER
  • 15 % off
     
    $ 4250
  • 20 % off
             
    $ 5650
  • 25 % off
         
    $ 7450
Pre-Purchase Inquiry
SEND AN INQUIRY
NEED CUSTOMIZATION?
Request Customization
CALL OR EMAIL US
US:
India:
Email:
100% Secure Payment

SPER American Express
SPER VISA
SPER Master Card
SPER Mestro
SPER Paypal
SPER CCAvenues

Have a glance of the Report

  Download Free Sample

Looking for Customization?

 Customization Request

Have a Question?

 Reach Our Analysis Team

COVID-19 impact analysis?

 Request Analysis

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.

SPER-Astellas Pharma
SPER-Microsoft
SPER-EY
SPER-McKinsey
SPER-Bain
SPER-Max-Healthcare
SPER-DHL
SPER-IQVIA
SPER-Mitsubishi Logistics
SPER-PACCOR
SPER-Macmillan Education
SPER-Kankar IMRB
SPER-ITA
SPER-PWC
SPER-SAPTCA
SPER-Straumann
SPER-MENARINI Silicon Biosystems
SPER-IPSOS
SPER-Heineken